Search for: "Wyeth Pharmaceuticals" Results 761 - 780 of 971
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Sep 2010, 2:40 am by Kelly
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US: PHOSITA:… [read post]
23 Mar 2007, 11:35 am
., Beckman Coulter, Bridgestone Americas, Bristol-Myers Squibb, Cargill Incorporated, Caterpillar, Cephalon, CheckFree, Corning, Dow Chemical, Eastman Chemical, Electronics for Imaging, E.I. du Pont (DuPont), Eli Lilly, ExxonMobil, General Electric, Genzyme, GlaxoSmithKline, Henkel Corporation, Hoffman-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals, Monsanto, Motorola, Novartis, Patent Café.com Inc., Pfizer, Procter & Gamble, Sangamo… [read post]
15 Feb 2011, 5:26 pm by Marie Louise
General Pharma backs calls for extension of TRIPS deadline for least-developed countries (IP Watch) Medicines Patent Pool in talks with Big Pharma (Spicy IP) Protect Pharma sells patent portfolio to Grunenthal GmbH (GenericsWeb) Australia: Federal Court upholds TGA decision to refuse access to documents relating to applications to list generics on the ARTG (IP Whiteboard) EU clarifies statement on ARVs (GenericsWeb) Mexico: Pharma patents in Mexico: an assessment of the current position (IP tango)… [read post]
9 Apr 2007, 11:19 pm
Wyeth Pharmaceuticals, No. 05-05720-JF, slip op. at 3 (E.D. [read post]
28 Apr 2011, 3:18 pm by Bexis
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
12 Sep 2023, 9:42 am by Mark Ashton
Pharmaceutical startups and those in the tech industry have been among those most reported. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA … [read post]
8 Aug 2013, 5:00 am by Bexis
Wyeth Pharmaceuticals, Inc., 287 S.W.3d 760, 770-71 (Tex. [read post]
25 Jan 2013, 12:47 pm by Bexis
It’s written somewhat strangely – weak at the beginning, strong at the end – but the Department of Justice’s amicus curiae brief , filed yesterday in Mutual Pharmaceutical Co. v. [read post]
6 Jul 2007, 4:29 am
Wyeth Laboratories, Inc., 533 N.E.2d 748, 755 (Ohio 1988). [read post]
28 Oct 2009, 7:15 am
(The SPC Blog) EU: European Federation of Pharmaceutical Industries and Associations unveils anti-counterfeit authentication system (IP Watch) US: Time Magazine on data exclusivity debate (Patent Docs) US: BIO’s IPCC Conference: Behind the scenes look at patent cases – Mayo v Prometheus; Bilski v Doll; Laboratory Court of Am. [read post]
8 May 2012, 5:59 pm by FDABlog HPM
  Plaintiffs sued several generic drug manufacturers, including Morton Grove Pharmaceuticals, Inc. [read post]
28 Oct 2009, 6:15 am
(The SPC Blog) EU: European Federation of Pharmaceutical Industries and Associations unveils anti-counterfeit authentication system (IP Watch) US: Time Magazine on data exclusivity debate (Patent Docs) US: BIO's IPCC Conference: Behind the scenes look at patent cases - Mayo v Prometheus; Bilski v Doll; Laboratory Court of Am. [read post]
28 Oct 2009, 6:15 am
(The SPC Blog) EU: European Federation of Pharmaceutical Industries and Associations unveils anti-counterfeit authentication system (IP Watch) US: Time Magazine on data exclusivity debate (Patent Docs) US: BIO's IPCC Conference: Behind the scenes look at patent cases - Mayo v Prometheus; Bilski v Doll; Laboratory Court of Am. [read post]
28 Nov 2011, 4:02 am by Max Kennerly, Esq.
Big pharmaceutical companies have wiped out most of the potential claims against them except for the “failure to warn,” and that’s a particularly tricky claim. [read post]
28 Jul 2008, 10:41 am
Indeed, state common-law tort actions based on the manufacturers’ failure to warn present the pharmaceutical manufacturers with particular difficulties. [read post]